Long-term outcome of cardiac function in a population-based cohort of breast cancer survivors: A cross-sectional study.
Liselotte M Boerman, Saskia W M C Maass, Peter van der Meer...
https://pubmed.ncbi.nlm.nih.gov/28601706Actively Recruiting
Led by University Medical Center Groningen · Updated on 2024-05-29
455
Participants Needed
1
Research Sites
52 weeks
Total Duration
U
University Medical Center Groningen
Lead Sponsor
Z
ZonMw: The Netherlands Organisation for Health Research and Development
Collaborating Sponsor
Researchers are investigating whether women who survived breast cancer at least five years ago and received chemotherapy and/or radiotherapy are at increased risk of long-term heart problems. This study compares cardiac function in these survivors to a similar group of women without cancer, aiming to find if monitoring heart health in breast cancer survivors is needed and to identify those at highest risk. It uses a longitudinal matched cohort design within primary care. The study involves two groups: breast cancer survivors diagnosed at least five years ago who underwent chemotherapy and/or radiotherapy, and an age- and general practitioner-matched group with no cancer history. The main assessment involves echocardiography, which measures heart dimensions, left and right ventricle function, valve status, heart rhythm, and other cardiac parameters. Participants will undergo echocardiography from October 2022 through December 2024 to assess left ventricular systolic dysfunction and other heart function markers. Researchers will track changes in heart function, cardiovascular diseases, and heart failure symptoms during the study. The study is observational and takes place in primary care, focusing on long-term outcomes in breast cancer survivors compared to matched controls.
CONDITIONS
Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 2 years
Participants undergo echocardiography to assess heart dimensions, left and right ventricle function, valve function, and other cardiac parameters.
Periodic visits for echocardiography assessments during the study period
Duration - Through study completion (from October 2022 to December 2024)
Participants are observed for the course of cardiac function, cardiovascular diseases, and symptoms of heart failure.
Follow-up visits aligned with diagnostic evaluations
Total: 1 location
1
University Medical Center Groningen
Groningen, Netherlands, 9700 AD
Actively Recruiting
D
Daan Brandenbarg, PhD
L
Laurine T van der Wal, MSc
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Liselotte M Boerman, Saskia W M C Maass, Peter van der Meer...
https://pubmed.ncbi.nlm.nih.gov/28601706